Non submission of Related Party Transaction in XBRL Mode under Reg. 23 (9) for the period ended 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals Ltd has informed BSE that it will not be submitting the Related Party Transaction (RPT) disclosure in XBRL format under Regulation 23(9) of SEBI LODR Regulations for the half-year ended 30 September 2025. The company states that this filing is not applicable to it because it qualifies for exemption under Regulation 15(2) of SEBI LODR. To qualify, a listed entity must have paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore, both as on the last day of the previous financial year. The company's paid-up equity share capital is ₹460.00 lakhs (₹4.60 crore) and its net worth is ₹482.85 lakhs (₹4.83 crore) as on 31 March 2025, both well below the thresholds. The letter is signed by Managing Director Zaver Shankarlal Bhanushali (DIN: 00663374) on 16 October 2025.
This is a routine regulatory/administrative communication and has no direct impact on shareholders or the stock price. It simply confirms that the company is too small (sub-₹10 crore capital, sub-₹25 crore net worth) to be required to file consolidated RPT disclosures, which is why no XBRL option exists for non-applicability.